Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3367
Actual shortage: 219 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 3138 (93%)

Discontinuation Reports

365
To be discontinued: 24 (7%)
Discontinued: 341 (93%)
Reversed: 0 (0%)

Late reports

144 (4%)

Overdue reports

68 (28%)
Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-AMLODIPINE-ATORVASTATIN 80MG 5MG TABLET Resolved 2022-02-04 2022-04-01 154168
APO-AMLODIPINE-ATORVASTATIN 5MG 80MG TABLET Resolved 2018-01-31 2018-07-03 37717
APO-AMLODIPINE-ATORVASTATIN 5MG 10MG TABLET Resolved 2018-02-01 2018-07-03 37945
APO-AMLODIPINE-ATORVASTATIN 10MG 80MG TABLET Resolved 2019-02-13 2019-04-22 75608
APO-AMLODIPINE-ATORVASTATIN 5MG 80MG TABLET Resolved 2019-02-13 2019-04-22 75641
APO-AMLODIPINE-ATORVASTATIN 10MG 80MG TABLET Resolved 2021-01-29 2021-05-26 132703
APO-AMLODIPINE-ATORVASTATIN 10MG 10MG TABLET Resolved 2017-06-08 2017-08-08 12278
APO-AMLODIPINE-ATORVASTATIN 5MG 20MG TABLET Resolved 2017-07-11 2017-08-08 15420
APO-AMLODIPINE-ATORVASTATIN 5MG 80MG TABLET Resolved 2017-08-14 2017-10-24 19213
APO-AMOXI 500MG CAPSULE Resolved 2024-12-05 2025-01-03 244926
APO-AMOXI 250MG POWDER FOR SUSPENSION Actual shortage 2025-05-08 2025-05-08 256914
APO-AMOXI 125MG POWDER FOR SUSPENSION Resolved 2020-11-04 2021-01-29 127751
APO-AMOXI 250MG POWDER FOR SUSPENSION Resolved 2022-06-17 2024-02-14 162918
APO-AMOXI 125MG POWDER FOR SUSPENSION Resolved 2022-08-12 2024-02-14 166621
APO-AMOXI 500MG CAPSULE Resolved 2022-11-27 2023-01-06 175904
APO-AMOXI 250MG CAPSULE Resolved 2022-12-05 2023-04-14 177129
APO-AMOXI 500MG CAPSULE Resolved 2019-10-23 2019-11-05 97034
APO-AMOXI 250MG POWDER FOR SUSPENSION Resolved 2020-01-08 2020-07-30 102528
APO-AMOXI 125MG POWDER FOR SUSPENSION Resolved 2020-03-04 2020-06-24 107690
APO-AMOXI 125MG POWDER FOR SUSPENSION Resolved 2020-07-08 2020-07-24 119693

Showing 321 to 340 of 3367

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-BISACODYL 5MG TABLET (DELAYED-RELEASE) Discontinued 2018-09-07 2018-09-15 60288
APO-BOSENTAN 62.5MG TABLET Discontinued 2019-01-04 2019-01-04 71339
APO-BOSENTAN 125.0MG TABLET Discontinued 2019-01-04 2019-01-04 71342
APO-BOSENTAN 125.0MG TABLET Discontinued 2018-09-07 2018-10-31 60291
APO-BRIMONIDINE 0.2% SOLUTION Discontinued 2018-09-07 2018-12-28 60301
APO-BRIMONIDINE 0.2% SOLUTION Discontinued 2020-11-16 2020-11-16 128438
APO-BRIMONIDINE 0.2% SOLUTION To be discontinued 2018-09-07 2018-09-07 60294
APO-BROMAZEPAM - TAB 1.5MG 1.5MG TABLET To be discontinued 2018-09-07 2018-09-07 60304
APO-BROMAZEPAM - TAB 3MG 3MG TABLET Discontinued 2018-09-07 2019-06-12 60307
APO-BROMAZEPAM - TAB 6MG 6MG TABLET Discontinued 2018-09-07 2018-10-19 60310
APO-CANDESARTAN 16MG TABLET Discontinued 2018-09-07 2018-09-15 60313
APO-CANDESARTAN 16MG TABLET Discontinued 2018-09-07 2018-09-15 60316
APO-CANDESARTAN 8MG TABLET Discontinued 2018-09-07 2018-09-15 60325
APO-CANDESARTAN 8MG TABLET Discontinued 2018-09-07 2018-09-15 60322
APO-CANDESARTAN 4MG TABLET Discontinued 2018-09-07 2018-09-15 60319
APO-CANDESARTAN 32MG TABLET Discontinued 2018-09-07 2018-09-15 60328
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-09-07 2018-09-15 60335
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-09-07 2018-09-15 60331
APO-CANDESARTAN/HCTZ 25MG 32MG TABLET Discontinued 2018-02-26 2018-05-03 41011
APO-CANDESARTAN/HCTZ 12.5MG 32MG TABLET Discontinued 2018-02-26 2018-02-26 41020

Showing 81 to 100 of 365